Missouri's Division of Cannabis Regulation (DCR), in partnership with NGWMO, LLC, is issuing an alert to patients and consumers about a mandatory product recall. Pursuant to 19 CSR 100-1.100(4)(P), DCR may issue a public notice of recall where marijuana product presents a potential threat to health and safety.
DCR is issuing a product recall on marijuana products sold to dispensary facilities by comprehensive cultivation licensee, NGWMO, LLC, CUL000069. The recalled marijuana products were not compliantly tested prior to being sold to patients and consumers. The recalled marijuana product was tested at the unprocessed bud/flower stage rather than being tested at the final marijuana product stage as required by 19 CSR 100-1.
Affected Products: The list of recalled products is located here.
No adverse reactions for these products have been reported to the DCR at this time.
Patients and consumers who have purchased the recalled product should discontinue use. All unused product(s) should be discarded or returned to the dispensary facility where purchased. Returned products will not count toward a patient’s purchase limit. For more information on returns, please contact the dispensary facility where the product was purchased. For information on recalled items, please go to DCR’s website.
Anyone who thinks that they may be experiencing adverse reactions should seek immediate medical attention.
Patients and consumers are reminded that any adverse reactions should be reported to [email protected] or fill out a complaint form located here.
